论文部分内容阅读
目的探讨盐酸氨溴索注射液联合盐酸丙卡特罗口服液治疗小儿肺炎的临床疗效。方法选取2013年5月—2015年5月景德镇市妇幼保健院收治的肺炎患儿90例,采用抽签的方式分为对照组与观察组,各45例。对照组患儿予以常规治疗,观察组患儿在对照组基础上予以盐酸氨溴索注射液联合盐酸丙卡特罗口服液治疗。观察两组患儿临床疗效、临床症状体征消退时间及不良反应发生情况。结果观察组患儿总有效率高于对照组,咳嗽消退时间、发热消退时间及啰音消失时间短于对照组,不良反应发生率低于对照组,差异有统计学意义(P<0.05)。结论盐酸氨溴索注射液联合盐酸丙卡特罗口服液治疗小儿肺炎的临床疗效显著,可缩短患儿临床症状消退时间,减轻患儿的痛苦,且不良反应少。
Objective To investigate the clinical efficacy of ambroxol hydrochloride injection and procaterol hydrochloride in the treatment of children pneumonia. Methods 90 cases of children with pneumonia admitted from May 2013 to May 2015 in Jingdezhen MCH were randomly divided into control group and observation group with 45 cases in each group. Children in the control group were treated routinely. Patients in the observation group were treated with Ambroxol Hydrochloride Injection and Procaterol Hydrochloride Oral Liquid on the basis of the control group. Clinical efficacy, clinical symptoms and signs of subsided time and adverse reactions were observed in two groups of children. Results The total effective rate in the observation group was higher than that in the control group. The cough subsided time, fever subsidence time and the disappearance time of rales were shorter than those in the control group. The incidence of adverse reactions was lower than that of the control group. The difference was statistically significant (P <0.05). Conclusion Ambroxol hydrochloride injection combined with Procaterol Hydrochloride Oral Liquid in the treatment of children with pneumonia is significant clinical efficacy, can shorten the clinical symptoms of children subsided time and reduce the pain of children with little adverse reactions.